HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydralazine Hydrochloride W/ Hydrochlorothiazide 50/50, and when can generic versions of Hydralazine Hydrochloride W/ Hydrochlorothiazide 50/50 launch?
Hydralazine Hydrochloride W/ Hydrochlorothiazide 50/50 is a drug marketed by Ivax Pharms and is included in one NDA.
The generic ingredient in HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50 is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
Summary for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50 at DailyMed |
Recent Clinical Trials for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Center for Research Resources (NCRR) | Phase 4 |
Vanderbilt University Medical Center | Phase 4 |
Vanderbilt University | Phase 1 |
See all HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50 clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50
US Patents and Regulatory Information for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ivax Pharms | HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50 | hydralazine hydrochloride; hydrochlorothiazide | CAPSULE;ORAL | 088357-001 | Apr 10, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |